Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCT
Comparison Between Spontaneous Breathing-preserving Anesthesia and Double-lumen Endotracheal Intubation Anesthesia in Early-stage Non-small Cell Lung Cancer With a Diameter of ≤ 3 cm: a Prospective, Multicenter Randomized Controlled Study
1 other identifier
interventional
410
0 countries
N/A
Brief Summary
This study is a prospective, randomized, controlled study, which intends to enroll patients with suspected early-stage NSCLC (non-small cell lung cancer) with a diameter of ≤ 3 cm as research subjects. The study is conducted in accordance with the Declaration of Helsinki. It has been approved by the Ethics Committee of the Second Affiliated Hospital of Air Force Medical University, and patients or their family members have signed the informed consent form. Patients undergoing VATS (video-assisted thoracic surgery) are enrolled in the Department of Thoracic Surgery of the Second Affiliated Hospital of Air Force Medical University. The patients are randomly divided into two groups: the NIVATS (non-intubated video-assisted thoracic surgery) group and the OLV (one-lung ventilation) group. By observing various perioperative indicators of the patients, the short-term efficacy of the two techniques in patients with early-stage NSCLC is compared, so as to evaluate the safety and effectiveness of the NIVATS surgical treatment method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedStudy Start
First participant enrolled
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2032
March 12, 2026
March 1, 2026
2.3 years
December 11, 2025
March 10, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Average postoperative hospital stay
up to 3 months
Intraoperative opioid consumption
1 day
Secondary Outcomes (10)
Lung collapse score
1 day
Intraoperative blood gas analysis (Q1h)
1 day
Conversion to intubation rate
1 day
Postoperative awakening time
1 day
Time to first ambulation after surgery
up to 3 months
- +5 more secondary outcomes
Other Outcomes (4)
The impact of nursing education on discharge time and time to first ambulation after surgery
up to 3 months
Comparison of the effects of thoracic paravertebral nerve block and intrathoracic intercostal nerve block
up to 3 months
1-, 3-, and 5-year disease-free survival (DFS)
up to 5 years
- +1 more other outcomes
Study Arms (2)
group A
EXPERIMENTALNon-intubated video-assisted thoracic surgery with spontaneous breathing (NIVATS)
group B
PLACEBO COMPARATORTracheal Intubation with One-Lung Ventilation Group (OLV)
Interventions
NIVATS is a special method developed in the past two decades. It means that patients do not undergo tracheal intubation under general anesthesia during the entire surgical process, retaining their spontaneous breathing, but supraglottic airway devices (such as laryngeal masks, high-flow nasal catheters, mask ventilation) can be used to support their breathing. The purpose of this technology is to minimize the impact of general anesthesia, tracheal intubation, mechanical ventilation, etc. on patients.
Eligibility Criteria
You may qualify if:
- Age ≤ 75 years;
- Gender is not limited;
- Patients with suspected T1 stage non-small cell lung cancer (NSCLC) in preoperative clinical staging, with thin-slice CT showing that the maximum tumor diameter is ≤ 3.0 cm, single or multiple nodules, and the nodules requiring surgical resection are located in the same ipsilateral lung lobe, with the number of nodules resected simultaneously ≤ 3;
- American Society of Anesthesiologists (ASA) classification ≤ Grade III (preferably Grade I - II is recommended);
- Eastern Cooperative Oncology Group (ECOG) performance status 0 - 1;
- Body Mass Index (BMI) \< 25 kg·m-²;
- Normal cardiopulmonary function: predicted forced expiratory volume in the first second (FEV1%) \> 50%, resting blood gas analysis showing arterial oxygen partial pressure (PaO2) ≥ 75 mmHg, arterial carbon dioxide partial pressure (PaCO2) \< 45 mmHg; ejection fraction (EF) \> 50%, 6-minute walk distance (6MWD) ≥ 350 m;
- No severe upper airway lesions, Mallampati classification I - II;
- No contraindications related to paravertebral nerve block and intercostal nerve block;
- Estimated surgical time ≤ 150 minutes;
- Patients have no history of clinically significant cardiac or neurological problems.
You may not qualify if:
- A history of ipsilateral lung surgery;
- Interstitial pneumonia, pulmonary fibrosis, severe emphysema, severe chronic obstructive pulmonary disease, acute phase of pulmonary infection, or uncontrolled asthma;
- Sleep apnea syndrome with anticipated airway difficulty or difficulty in airway management;
- Preoperative complications including coagulation dysfunction, hypoxemia, hypercapnia, or hepatic/renal insufficiency;
- Alteration of anesthesia or surgical plan;
- Persistent cough or increased risk of high airway secretion reflux;
- Mental disorders, inability to communicate, or refusal to sign the informed consent form;
- Participation in other clinical trials within 1 month before this trial;
- Those who are deemed unfit to participate in this trial by the researchers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tang-Du Hospitallead
Related Publications (8)
Pompeo E, Mineo D, Rogliani P, Sabato AF, Mineo TC. Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules. Ann Thorac Surg. 2004 Nov;78(5):1761-8. doi: 10.1016/j.athoracsur.2004.05.083.
PMID: 15511470BACKGROUNDPompeo E. State of the art and perspectives in non-intubated thoracic surgery. Ann Transl Med. 2014 Nov;2(11):106. doi: 10.3978/j.issn.2305-5839.2014.10.01.
PMID: 25489580BACKGROUNDChiang XH, Lin MW. Converting to Intubation During Non-intubated Thoracic Surgery: Incidence, Indication, Technique, and Prevention. Front Surg. 2021 Oct 26;8:769850. doi: 10.3389/fsurg.2021.769850. eCollection 2021.
PMID: 34765639BACKGROUNDLohser J, Slinger P. Lung Injury After One-Lung Ventilation: A Review of the Pathophysiologic Mechanisms Affecting the Ventilated and the Collapsed Lung. Anesth Analg. 2015 Aug;121(2):302-18. doi: 10.1213/ANE.0000000000000808.
PMID: 26197368BACKGROUNDHung WT, Hung MH, Wang ML, Cheng YJ, Hsu HH, Chen JS. Nonintubated Thoracoscopic Surgery for Lung Tumor: Seven Years' Experience With 1,025 Patients. Ann Thorac Surg. 2019 Jun;107(6):1607-1612. doi: 10.1016/j.athoracsur.2019.01.013. Epub 2019 Feb 11.
PMID: 30763562BACKGROUNDGelzinis TA, Sullivan EA. Non-Intubated General Anesthesia for Video-Assisted Thoracoscopic Surgery. J Cardiothorac Vasc Anesth. 2017 Apr;31(2):407-408. doi: 10.1053/j.jvca.2016.12.027. Epub 2016 Dec 23. No abstract available.
PMID: 28320572BACKGROUNDJanik M, Juhos P, Lucenic M, Tarabova K. Non-intubated Thoracoscopic Surgery-Pros and Cons. Front Surg. 2021 Dec 6;8:801718. doi: 10.3389/fsurg.2021.801718. eCollection 2021.
PMID: 34938770BACKGROUNDLiu J, Cui F, He J. Non-intubated video-assisted thoracoscopic surgery anatomical resections: a new perspective for treatment of lung cancer. Ann Transl Med. 2015 May;3(8):102. doi: 10.3978/j.issn.2305-5839.2015.04.18.
PMID: 26046043BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2025
First Posted
January 8, 2026
Study Start
March 15, 2026
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
December 31, 2032
Last Updated
March 12, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share